two
categori
inorgan
miner
compound
appli
immunolog
adjuv
vaccin
formul
aluminum
compound
calcium
phosphat
two
aluminum
compound
longest
histori
far
comprehens
record
use
adjuv
gener
regard
safe
use
human
vaccin
use
accord
current
vaccin
schedul
glenni
cowork
first
demonstr
adjuv
effect
aluminum
compound
glenni
prepar
varieti
diphtheria
toxoid
precipit
investig
immunogen
among
toxoid
precipit
addit
potassium
alum
kal
glenni
observ
inject
diphtheria
toxoid
alum
precipit
led
signific
increas
immun
respons
toxoid
vaccin
prepar
accord
principl
use
practic
vaccin
refer
alumprecipit
vaccin
approach
howev
number
drawback
found
prepar
could
highli
heterogen
depend
anion
bicarbon
sulfat
phosphat
present
time
precipit
eg
buffer
constitu
growth
media
residu
antigen
solut
addit
al
precipit
antigen
take
place
alkalin
condit
may
case
introduc
alter
antigen
contrast
preform
aluminum
hydroxid
form
hydrat
colloid
gel
abil
adsorb
protein
antigen
aqueou
solut
gel
preform
welldefin
standard
way
vaccin
prepar
base
adsorpt
antigen
onto
preform
aluminum
hydroxid
adjuv
refer
aluminumadsorb
vaccin
contrast
alumprecipit
vaccin
mention
earlier
data
use
alumprecipit
vaccin
found
older
literatur
practic
vaccin
adsorpt
onto
preform
aluminum
hydroxid
aluminum
phosphat
gel
almost
complet
substitut
alum
precipit
vaccin
formul
aluminum
phosphat
introduc
altern
adjuv
two
decad
glenni
work
han
ericsson
sweden
devis
method
diphtheria
toxoid
coprecipit
matrix
aluminum
phosphat
correspond
alum
precipit
method
describ
earlier
lewi
b
holt
demonstr
follow
year
preform
aluminum
phosphat
prepar
aluminum
chlorid
trisodium
phosphat
act
adsorb
adjuvantact
diphtheria
toxoid
aluminum
hydroxid
includ
composit
adjuv
formul
adjuv
formul
proprietari
glaxo
smithklin
consist
aluminum
hydroxid
combin
monophosphoryl
lipid
mpl
occasion
word
alum
seen
adjuv
literatur
describ
aluminum
hydroxid
aluminum
phosphat
gel
incorrect
use
terminolog
potassium
alum
kal
accord
chemic
definit
alum
wherea
neither
aluminum
hydroxid
aluminum
phosphat
calcium
phosphat
develop
adjuv
edgar
h
relyveld
relyveld
person
commun
also
case
calcium
phosphat
adjuv
coprecipit
presenc
antigen
preform
care
control
chemic
environ
subsequ
use
adsorpt
antigen
question
aluminum
hydroxid
aluminum
phosphat
adjuv
gener
prepar
expos
aqueou
solut
aluminum
salt
typic
sulfat
chlorid
alkalin
condit
welldefin
control
chemic
environ
variou
solubl
aluminum
salt
use
product
aluminum
hydroxid
experiment
condit
temperatur
concentr
even
rate
addit
reagent
strongli
influenc
result
anion
present
time
prepar
may
coprecipit
chang
characterist
pure
aluminum
hydroxid
aluminum
phosphat
gel
seen
exampl
prepar
solubl
aluminum
salt
precipit
presenc
suffici
amount
phosphat
ion
xray
microanalysi
fig
way
obtain
ground
element
fingerprint
miner
adjuv
prepar
give
indic
salt
use
start
materi
prepar
stanley
hem
group
purdu
univers
studi
physicochem
natur
inorgan
miner
gel
prepar
commonli
use
vaccin
adjuv
year
use
xray
crystallographi
infrar
spectroscopi
demonstr
boehmitelik
aluminum
oxyhydroxid
alooh
pattern
prepar
tradit
known
aluminum
hydroxid
wherea
commerci
aluminum
phosphat
gel
adjuv
identifi
amorph
aluminum
hydroxyphosph
possibl
calcul
averag
primari
crystallit
size
nm
boehmit
prepar
commerci
avail
calcium
phosphat
rehei
inc
nj
usa
studi
xray
diffract
fourier
transform
infrar
spectroscopi
thermal
analysi
indic
calcium
phosphat
adjuv
suggest
formula
ca
po
could
describ
nonstoichiometr
hydroxyapatit
ca
hpo
x
po
oh
x
vari
origin
work
relyveld
describ
calcium
phosphat
adjuv
prepar
institut
pasteur
nonhydroxyapatit
relyveld
person
commun
morpholog
studi
use
scan
electron
microscopi
sem
perform
fig
howev
rememb
dehydr
adjuv
particl
prepar
sem
may
lead
structur
complet
ident
present
immun
system
vaccin
adjuv
human
vaccin
aluminum
adjuv
primarili
use
tetanu
diphtheria
pertussi
poliomyel
vaccin
part
standard
childhood
vaccin
program
year
mani
countri
later
aluminum
adjuv
also
introduc
hepat
hepat
b
viru
vaccin
well
vaccin
human
papillomaviru
caus
genit
wart
cervic
cancer
vaccin
lyme
diseaseborrelios
japanes
enceph
aluminumadsorb
vaccin
eg
anthrax
avail
special
risk
group
tabl
veterinari
medicin
aluminum
adjuv
use
larg
number
vaccin
formul
viral
bacteri
diseas
tabl
well
attempt
make
antiparasit
vaccin
calcium
phosphat
use
adjuv
vaccin
diphtheria
tetanu
bordetella
pertussi
poliomyel
commerci
institut
pasteur
calcium
phosphat
use
adjuv
ipad
seri
vaccin
institut
pasteur
approxim
year
furthermor
calcium
phosphat
test
adjuv
experiment
vaccin
formul
antigen
human
immunodefici
viru
calcium
phosphat
far
use
adjuv
commerci
veterinari
prophylact
vaccin
aluminum
hydroxid
calcium
phosphat
use
adjuv
commerci
adsorb
allergen
prepar
hyposensit
allerg
patient
limit
applic
miner
adjuv
one
obviou
limit
applic
aluminum
adjuv
lie
appar
profil
adjuv
immun
respons
like
protect
diseas
immun
major
histocompat
complex
mhc
class
ierestrict
ctl
essenti
protect
eg
intracellular
parasit
tuberculosi
anoth
limit
lie
fact
tradit
aluminumand
calciumadsorb
vaccin
sensit
freez
therefor
lyophiliz
assay
detect
damag
vaccin
formul
induc
freez
publish
attempt
made
overcom
sensit
freez
ad
lyoprotect
trehalos
prepar
aluminum
adjuv
fail
provid
satisfactori
augment
immun
respons
number
infecti
diseas
influenza
typhoid
fever
vaccin
approach
vaccin
prepar
aluminum
adjuv
shown
limit
applic
vaccin
base
smallsiz
peptid
case
eg
foot
mouth
diseas
fmd
viru
peptid
problem
could
overcom
conjug
peptid
larger
carrier
molecul
other
could
aluminum
adjuv
test
dna
vaccin
formul
shown
aluminum
hydroxid
inhibit
effect
wherea
aluminum
phosphat
adjuv
augment
immun
respons
antigen
encod
dna
nucleotid
content
phosphat
dna
molecul
appar
give
high
bind
affin
aluminum
hydroxid
turn
prevent
effici
transcript
translat
protein
recent
shown
certain
metal
ion
potenti
present
miner
adjuv
formul
may
destabil
effect
vaccin
stabil
schlegl
et
al
demonstr
high
amount
residu
cu
ion
could
interact
sodium
metabisulfit
ad
vaccin
formul
neutral
formaldehyd
lead
format
free
radic
would
turn
react
antigen
integr
result
significantli
reduc
shelf
life
vaccin
exemplifi
commerci
vaccin
japanes
enceph
viru
ixiaro
limit
content
aluminum
calcium
allow
vaccin
human
administ
adjuv
limit
mg
aluminum
per
dose
europ
unit
state
limit
mg
aluminum
per
dose
determin
assay
mg
determin
calcul
mg
safeti
efficaci
data
justifi
europ
maximum
allow
amount
calcium
deliv
calcium
phosphateeadjuv
vaccin
mg
ca
howev
obviou
toxicolog
rational
behind
limit
amount
calcium
vaccin
mgdose
calcium
phosphat
natur
constitu
mammal
compon
bone
replac
transplant
much
higher
amount
toxicolog
problem
optimum
dose
adjuv
normal
determin
empir
pilot
trial
help
guidelin
avail
literatur
veterinari
vaccin
defin
maximum
limit
allow
content
aluminum
adjuv
dose
normal
set
balanc
efficaci
local
reactogen
doseerespons
relat
type
miner
adjuv
combin
bacteri
antigen
immunomodul
observ
may
reflect
composit
effect
miner
adjuv
immunomodulatori
adjuvantact
bacteri
substanc
known
pathogenassoci
molecular
pattern
pamp
tolllik
receptor
tlr
agonist
muramyl
peptid
peptidoglycan
lipopolysaccharid
lp
trehalos
dimycol
cord
factor
cpg
motif
bacteri
dna
immunostimul
effect
tradit
aluminum
adjuv
highli
complex
must
attribut
sever
differ
mechan
older
literatur
function
repositori
adjuv
origin
describ
delay
clear
inject
site
sustain
gradual
releas
adsorb
antigen
inocul
depot
although
gradual
releas
delay
clear
may
inde
play
role
quickli
becam
obviou
gradual
releas
insuffici
explain
mechan
adjuv
activ
howev
physic
adsorpt
characterist
antigen
onto
adjuv
still
consid
import
mechan
function
miner
adjuv
literatur
hold
exampl
public
inject
adjuv
unadsorb
antigen
distant
site
led
immunostimul
toward
antigen
howev
consist
pictur
natur
antigen
chosen
work
may
provid
part
explan
deviat
conclus
gener
rule
antigen
adsorb
onto
adjuv
prior
immun
adsorpt
care
monitor
consequ
physic
attach
antigen
onto
adjuv
solubl
antigen
upon
adsorpt
may
present
immunocompet
cell
particul
manner
could
facilit
antigen
target
ie
favor
uptak
antigenpres
cell
apc
like
explan
apc
may
effici
antigen
uptak
phagocytosi
pinocytosi
mannhalt
cowork
convincingli
demonstr
enhanc
uptak
well
antigen
present
measur
tcell
prolifer
aluminumadsorb
tetanu
toxoid
compar
solubl
toxoid
human
apc
vitro
physicochem
mechan
behind
antigen
adsorpt
complex
depend
upon
natur
individu
antigen
characterist
adjuv
particl
mechan
may
predomin
other
primari
mechan
respons
adsorpt
explain
partli
electrostat
attract
partli
anion
ligand
exchang
addit
intermolecular
bind
forc
like
hydrophilicehydrophob
interact
van
der
waal
forc
may
play
role
protein
adsorpt
bind
forc
play
role
given
antigeneadjuv
combin
depend
upon
natur
antigen
chemic
environ
ph
ionic
strength
presenc
surfact
etc
gener
guidelin
adsorpt
electrostat
attract
accomplish
ph
interv
isoelectr
point
iep
protein
antigen
point
zero
charg
pzc
adjuv
equival
iep
adjuv
appli
aluminum
hydroxid
aluminum
phosphat
adjuv
interv
adjuv
antigen
opposit
electr
charg
facilit
electrostat
attract
adsorpt
fig
surfac
charg
sch
millivolt
adjuv
particl
c
describ
formula
stanley
l
hem
person
commun
formula
deriv
nernst
equat
pzc
ph
valu
net
charg
adjuv
zero
ph
actual
ph
valu
chemic
environ
salli
seeber
cowork
conclud
aluminum
hydroxid
superior
aluminum
phosphat
adsorb
protein
acid
iep
vice
versa
protein
alkalin
iep
howev
antigen
distinct
polar
term
one
part
molecul
clearli
acid
iep
distant
part
molecul
clearli
alkalin
iep
may
bind
well
eg
al
oh
alpo
electrostat
attract
howev
case
may
differ
orient
adsorb
molecul
relat
adjuv
ligand
exchang
antigen
contain
phosphoryl
group
eg
phosphoryl
amino
acid
ligand
exchang
antigenassoci
phosphat
hydroxyl
group
adjuv
may
account
highaffin
bind
adjuv
case
eg
hepat
b
viru
surfac
antigen
hbsag
particl
shown
experi
use
phosphoryl
alphacasein
model
antigen
ligand
exchang
involv
substitut
surfaceassoci
hydroxyl
group
phosphat
group
lead
decreas
pzc
adjuv
adsorpt
due
ligand
exchang
may
take
place
even
system
adjuv
antigen
electr
charg
electrostat
repuls
would
expect
determin
protein
adsorpt
capac
adjuv
highli
recommend
measur
varieti
analyt
method
normal
done
compar
protein
content
aqueou
phase
antigen
solut
adsorpt
onto
adjuv
antibodi
specif
antigen
one
wish
adsorb
avail
adsorpt
measur
immunoprecipit
techniqu
done
quantit
immunoelectrophoresi
singl
radial
immunodiffus
without
use
antibodi
test
spectrophotometr
eg
bicinchonin
acid
bca
method
howev
one
awar
contamin
fine
fraction
miner
gel
particl
disturb
spectrophotometr
read
lightscatt
effect
enzymelink
immunosorb
assay
elisa
method
design
aluminumadsorb
antigen
could
use
directli
antigen
elisa
assay
elisa
method
also
appli
vitro
assess
variou
viral
antigen
ie
pseudorabi
porcin
parvoviru
infecti
bovin
rhinotrach
vaccin
adsorb
onto
aluminum
hydroxid
adjuv
differenti
adsorpt
complex
mixtur
antigen
measur
either
immunoelectrophoresi
highperform
liquid
chromatographi
hplc
antiserum
rais
complex
antigen
mixtur
avail
cross
twodimension
immunoelectrophoresi
may
reveal
singl
compon
complex
solut
protein
remain
unadsorb
use
approach
precipit
band
pattern
electrophoresi
run
complex
antigen
mixtur
prior
adsorpt
compar
band
electrophoresi
run
supernat
mixtur
adsorpt
unadsorb
compon
retain
immunoprecipit
band
pattern
wherea
miss
band
reduc
height
band
indic
complet
partial
protein
adsorpt
hplc
chromatogram
antigen
mixtur
liquid
phase
adsorpt
may
provid
similar
type
inform
test
adsorpt
power
miner
adjuv
use
diphtheria
tetanu
vaccin
old
ramon
floccul
test
still
frequent
use
test
result
given
lf
limit
floccul
relev
distinguish
adsorpt
capac
amount
antigen
adsorb
monolay
coverag
adjuv
adsorpt
coeffici
measur
strength
adsorpt
forc
least
sinc
evid
high
adsorpt
coeffici
may
lead
reduct
immun
respons
variou
mathemat
model
use
describ
protein
adsorpt
quantit
adsorpt
molecul
surfac
like
antigen
adjuv
particl
govern
equilibrium
thermodynam
kinet
principl
proport
surfac
cover
adsorb
equilibrium
principl
depend
adsorb
concentr
rate
constant
adsorpt
desorpt
given
temperatur
pressur
simplest
form
process
describ
langmuir
isotherm
origin
deriv
describ
adsorpt
ga
molecul
simpl
planar
surfac
appli
adsorpt
molecul
solut
solid
interfac
relat
quantiti
solut
molecul
q
bound
surfac
adsorb
concentr
given
follow
function
rectangular
hyperbola
q
max
maxim
quantiti
adsorb
molecul
k
eq
equilibrium
constant
equat
also
written
proport
site
occupi
surfac
q
q
qq
max
function
concentr
adsorb
strength
model
make
popular
attract
base
physic
theori
allow
simpl
data
fit
procedur
eg
nonlinear
leastsquar
method
extract
equilibrium
constant
measur
bind
strength
adsorb
surfac
howev
despit
popular
langmuir
isotherm
rare
correspond
physic
realiti
macromolecul
adsorpt
adjuv
surfac
underli
assumpt
gener
violat
homogen
bind
site
dynam
equilibrium
time
measur
interact
adsorb
due
complex
natur
macromolecul
protein
antigen
interact
surfac
typic
rough
inhomogen
equilibria
condit
might
achiev
time
record
dispar
multival
natur
proteinbind
site
surfac
structur
remodel
upon
adsorpt
proteineprotein
interact
high
concentr
etc
topic
discuss
reader
refer
work
latour
langmuir
isotherm
fit
langmuirlook
data
plot
often
risk
underevalu
k
eq
paramet
associ
free
gibb
energi
valu
potenti
draw
erron
conclus
addit
k
eq
valu
high
shape
rectangular
hyperbola
dynam
rang
data
point
collect
becom
compress
make
effect
concentr
rang
limit
experiment
impract
handl
order
correct
limit
langmuir
isotherm
model
later
develop
better
suit
fit
data
heterogen
system
hybrid
model
combin
langmuir
freundlich
isotherm
toth
isotherm
better
satisfi
lower
upper
rang
adsorb
concentr
two
model
deriv
short
exhaust
review
adsorpt
isotherm
see
foo
hame
toth
equat
take
follow
form
seen
equat
includ
addit
paramet
reduc
langmuir
equat
paramet
quantifi
deviat
ideal
system
formul
langmuir
indic
level
heterogen
adsorpt
process
typic
experi
would
consist
measur
amount
molecul
bound
surfac
adsorb
function
adsorb
concentr
use
variou
techniqu
satur
surfac
achiev
case
insolubl
adjuv
particl
like
aluminum
hydroxid
aluminum
phosphat
calcium
phosphat
amount
adsorb
antigen
measur
indirectli
differ
initi
concentr
solut
final
concentr
equilibrium
physic
separ
insolubl
adjuv
eg
sediment
filtrat
amount
bound
adsorb
plot
function
adsorb
concentr
typic
exampl
equilibrium
fraction
satur
given
fig
lysozym
adsorb
adjupho
particl
data
fit
model
isotherm
langmuir
toth
fig
one
observ
linear
increas
bound
fraction
low
concentr
lysozym
follow
gradual
inflect
plot
concentr
increas
reach
asymptot
region
site
becom
occupi
fig
besid
appar
k
eq
relev
inform
experimentalist
maxim
amount
bound
adsorb
q
max
per
surfac
area
weight
particul
materi
valu
asymptot
use
determin
maxim
vaccin
dose
final
fit
q
valu
give
fraction
site
occupi
also
valuabl
inform
determin
work
concentr
antigen
need
achiev
desir
coverag
adjuv
particl
reduc
concentr
ie
amount
antigen
achiev
similar
site
occup
also
prove
econom
expens
antigen
figur
henegg
lysozym
adsorpt
isotherm
adjupho
raw
data
fit
two
model
isotherm
langmuir
solid
line
toth
dot
line
data
point
fit
use
nonlinear
least
squar
regress
paramet
extract
fit
r
adjust
coeffici
determin
b
max
maxim
amount
adsorb
molecul
nmole
k
eq
appar
equilibrium
constant
litermol
expon
toth
equat
increas
concentr
lysozym
admix
fix
amount
buffer
adjupho
particl
ae
mm
diamet
mv
zpotenti
suspend
imidazol
mm
ph
incub
c
min
appar
equilibria
reach
within
min
adsorb
lysozym
deduc
differ
ultraviolet
absorb
nm
initi
solut
admixtur
supernat
centrifug
sediment
particl
final
one
emphas
variabl
extract
fit
two
isotherm
differ
expect
notic
good
fit
measur
adjust
r
toth
isotherm
slightli
improv
langmuir
isotherm
fig
suggest
particular
system
mechan
adsorpt
appear
deviat
langmuir
model
situat
may
differ
system
signific
deviat
langmuir
isotherm
encount
also
notic
somewhat
differ
valu
q
max
maxim
quantiti
adsorb
molecul
k
eq
obtain
two
model
fig
remind
critic
judgment
exert
upon
signific
older
literatur
aluminum
adjuv
often
claim
tcell
adjuv
howev
mostli
base
work
period
tcell
adjuv
primarili
adjuv
capabl
induc
delayedtyp
hypersensit
dth
respons
gener
consid
simpl
obsolet
correct
aluminum
adjuv
effici
dth
induc
rodent
point
robert
bomford
also
littl
evid
aluminum
adjuv
abl
gener
mhc
class
ierestrict
cytotox
cell
far
singl
report
dillon
cowork
use
recombin
influenza
vaccin
mice
howev
earli
abil
aluminum
adjuv
induc
eosinophilia
shown
requir
presenc
cell
reaction
profil
aluminum
adjuv
shown
compris
stimul
cell
among
earli
observ
classic
anim
model
demonstr
mannhalt
aluminumadsorb
tetanu
toxoid
led
increas
antigeninduc
tcell
prolifer
appar
due
increas
releas
contrast
lack
import
augment
primari
antibodi
respons
rabbit
immun
aluminum
adjuv
grun
maurer
demonstr
abl
inhibit
antigenspecif
tcell
prolif
respons
immun
aluminum
adjuv
case
mice
immun
freund
complet
adjuv
howev
prolif
respons
inhibit
antibodi
regardless
adjuv
use
indic
prolifer
cell
mice
immun
use
aluminum
adjuv
subset
lindblad
cowork
found
correspond
profil
mice
perform
revers
transcriptasepolymeras
chain
reaction
messeng
rna
mrna
region
drain
lymph
node
day
follow
vaccin
aluminumadjuv
vaccin
interest
complex
al
oh
al
oh
induc
respons
rather
respons
use
adjuv
effect
al
oh
complex
greatli
augment
coadministr
exogen
new
line
research
initi
introduct
gene
knockout
mice
sinc
facilit
studi
signific
interleukin
adjuvantmedi
immunostimul
gene
knockout
mice
immun
ovalbumin
ova
al
oh
elicit
titer
similar
magnitud
ova
inject
togeth
freund
complet
adjuv
fca
interestingli
group
immun
al
oh
continu
produc
cytokin
normal
associ
profil
contrast
mice
immun
use
fca
similar
stimul
seen
support
idea
major
role
aluminuminduc
thsubset
stimul
downregul
respons
later
studi
jim
brewer
group
show
use
either
mice
although
mice
unabl
process
signal
abil
aluminum
hydroxid
induc
abrog
higher
level
found
mice
wildtyp
mice
suggest
stimul
mice
could
due
overlap
respons
sinc
util
common
signal
pathway
via
receptor
howev
conclud
respons
could
due
sinc
respons
impair
mice
role
adjuv
activ
aluminum
hydroxid
effect
induct
studi
brewer
group
demonstr
mice
immun
ova
al
oh
reduc
product
lymph
node
cell
compar
wildtyp
mice
howev
ad
exogen
enhanc
aluminuminduc
respons
although
aluminum
adjuv
led
reduc
product
mice
accompani
reduc
level
serum
appar
poor
correl
particular
antibodi
subclass
product
calcium
phosphat
cytokin
data
yet
found
literatur
yet
possibl
investig
surfac
marker
differenti
time
cell
popul
vivo
due
biolog
complex
live
organ
howev
vitro
model
may
lead
observ
valid
may
later
challengedd
due
care
takendbi
vivo
control
experi
ulanova
et
al
among
first
carri
systemat
studi
direct
effect
aluminum
hydroxid
cultur
human
peripher
blood
mononuclear
cell
pbmc
found
increas
express
costimulatori
adhes
molecul
mhc
class
ii
formerli
known
intercellular
adhes
molecul
formerli
known
lymphocyt
functionassoci
antigen
matur
marker
formerli
known
monocyt
well
increas
mrna
howev
presenc
antibodi
highli
purifi
monocyt
cultur
ie
deplet
cell
increas
mhc
class
ii
express
appar
aluminum
adjuvanteinduc
monocytederiv
cytokin
stimul
cell
secret
turn
stimul
mhc
class
ii
express
monocyt
surfac
rimaniol
cowork
cultiv
human
monocyt
pbmc
medium
alon
medium
contain
aluminum
hydroxid
adjuv
observ
phenotyp
macrophag
chang
chang
encount
involv
signific
upregul
hladr
well
almost
macrophag
obtain
posit
scaveng
receptor
howev
incub
aluminum
hydroxid
downregul
fc
g
r
macrophag
express
dendrit
cell
dc
elik
phenotyp
incub
aluminum
hydroxid
hladr
high
high
investig
express
dce
specif
marker
express
increas
h
incub
aluminum
hydroxid
compar
noneal
oh
stimul
cell
turn
adjuvantstimul
macrophag
also
superior
antigen
present
base
find
rimaniol
et
al
conclud
stimul
aluminum
adjuv
led
differenti
macrophag
form
share
featur
still
distinctli
differ
dc
similar
data
moment
avail
calcium
phosphat
adjuv
group
univers
lausann
head
urg
tschopp
defin
inflammasom
molecular
platform
trigger
activ
inflammatori
caspas
process
proilb
initi
new
line
research
lead
possibl
explan
mechan
action
aluminum
adjuv
earli
phase
immun
respons
stimul
excret
proinflammatori
cytokin
accord
approach
uptak
aladjuv
vaccin
dc
accompani
k
efflux
three
intracellular
protein
known
also
known
cryopyrin
cardin
asc
join
form
socal
inflammasom
fig
possibl
phagosom
destabil
upon
assembl
inflammasom
induc
cleavag
turn
activ
enzym
abl
cleav
activ
counterpart
leav
dc
activ
proinflammatori
cytokin
mice
signific
increas
seen
compar
level
seen
mice
receiv
salin
antigen
alon
sinc
process
could
take
place
mice
consid
depend
synthesi
affect
tlr
agonist
react
tlr
surfac
dc
upon
reaction
surfaceassoci
tlr
believ
nuclear
factor
nf
kb
pathway
activ
gene
transcrib
nucleu
dc
addit
mechan
may
hypothet
contribut
avail
vivo
exampl
antigen
may
contain
pamp
therebi
fulfil
function
tlr
agonist
draw
line
back
origin
sustainedreleas
theori
antigen
releas
aladjuv
depot
consequ
interact
interstiti
fluid
may
expos
antigenassoci
pamp
surfac
tlr
nearbi
dc
attract
inoculum
inject
site
appar
activ
inflammasom
dc
limit
consequ
uptak
aluminum
adjuv
inflammasom
also
activ
uptak
eg
uric
acid
crystal
uric
acid
crystal
power
danger
signal
releas
die
cell
breakdown
product
nucleic
acid
appear
combin
two
view
suggest
phagocyt
cell
take
aluminum
adjuv
may
releas
uric
acid
crystal
danger
signal
stimul
format
inflammasom
dc
remain
establish
danger
signal
kda
heat
shock
protein
also
lead
stimul
inflammasom
indic
may
case
one
observ
consid
support
report
alexzand
asea
group
harvard
medic
school
demonstr
extracellular
ad
human
monocyt
cultur
elicit
rapid
intracellular
ca
flux
activ
nuclear
factor
nfkb
upregul
express
proinflammatori
cytokin
tnfa
followup
studi
demonstr
util
receptor
proinflammatori
signal
transduct
fashion
studi
literatur
suggest
differ
profil
relat
stimul
ige
aluminumand
calciumbas
adjuv
abil
aluminum
adjuv
stimul
product
ige
part
overal
profil
wellestablish
although
often
mention
disadvantag
difficult
demonstr
case
vaccin
aluminum
adjuv
led
igemedi
allergi
toward
vaccin
antigen
practic
vaccin
contrast
aluminum
adjuv
use
hyposensit
allerg
patient
mani
year
good
result
eg
alutard
seri
vaccin
tabl
much
work
ige
stimul
aluminum
adjuv
anim
model
carri
use
dual
setup
model
rodent
immun
use
either
aluminum
adjuv
fca
respect
antibodi
cytokin
profil
compar
ued
cowork
japan
pioneer
line
research
three
decad
ago
use
keyhol
limpet
hemocyanin
antigen
demonstr
involv
glycosylationenhanc
factor
fc
g
r
cell
dichotom
regulatori
pathway
aluminum
adjuv
stimul
synthesi
ige
wherea
fca
suppress
brewer
cowork
use
approach
compar
adjuv
profil
aluminum
hydroxid
vs
fca
use
genedisrupt
mice
found
ige
product
genedisrupt
mice
regardless
whether
aluminum
adjuv
fca
use
adjuv
suggest
essenti
prerequisit
induct
ige
aluminum
adjuv
literatur
data
suggest
calcium
phosphat
adjuv
lead
signific
stimul
ige
antibodi
vassilev
compar
passiv
cutan
anaphylaxia
guinea
pig
two
immun
either
aluminum
calcium
phosphat
adjuv
use
tetanu
toxoid
antigen
found
calcium
phosphateeadjuv
guinea
pig
insignific
ige
titer
compar
group
receiv
aladjuv
vaccin
gener
research
field
spars
present
data
interleukin
profil
immun
calcium
phosphat
illustr
possibl
underli
differ
mechan
behind
differ
interest
similar
immun
respons
eg
stimul
ige
eosinophilia
elicit
helminth
parasit
immun
respons
follow
immun
aluminum
adjuv
make
adjuv
interest
candid
antiparasit
vaccin
earli
experiment
data
suggest
protect
superior
specif
ige
aluminumadjuv
vaccin
anim
model
schistosomiasi
infect
aluminum
normal
found
blood
serum
human
anim
whether
vaccin
use
aluminum
adjuv
major
sourc
aluminum
appar
oral
intak
food
drink
water
person
normal
kidney
function
known
excret
aluminum
urin
wherea
person
impair
renal
function
may
extent
accumul
may
lifelong
exposur
reach
al
level
associ
system
advers
reaction
exposur
aluminum
vaccin
seen
lifetim
minim
compar
daili
intak
aluminum
drink
water
antiperspir
food
addit
conveni
food
exampl
bread
made
aluminumbas
bake
powder
may
contain
mg
aluminum
per
slice
process
american
chees
contain
much
mg
aluminum
per
slice
even
taken
consider
littl
ingest
aluminum
may
taken
gastrointestin
tract
exposur
aluminum
use
adsorb
vaccin
normal
vaccin
schedul
still
minim
comparison
martyn
cowork
base
studi
britain
report
averag
daili
intak
aluminum
human
drink
water
mg
major
differ
aluminumand
calciumbas
adjuv
lie
vivo
clear
adjuv
inoculum
metabol
fate
degrad
product
upon
degrad
calcium
phosphat
two
constitu
reutil
normal
physiolog
pathway
ca
po
respect
wherea
contrast
metal
ion
like
zn
mg
aluminum
appar
act
essenti
trace
element
coenzym
normal
metabol
howev
previou
claim
aluminum
adjuv
broken
situ
excret
shown
incorrect
vivo
clear
parent
administ
aluminum
adjuv
investig
rabbit
flarend
et
al
use
adjuv
prepar
isotop
al
bloodand
urineexcret
al
follow
use
acceler
mass
spectroscopi
period
day
earli
h
follow
intramuscular
im
inject
radioact
label
al
could
detect
blood
found
approxim
three
time
al
excret
anim
vaccin
aluminum
phosphat
vaccin
aluminum
hydroxid
assumingli
interstiti
fluid
contain
organ
acid
ahydroxi
carboxyl
acid
abl
chelat
al
react
readili
aluminum
phosphat
aluminum
hydroxid
day
rabbit
euthan
main
organ
digest
use
nitric
acid
radioact
measur
rel
tissu
distribut
radiolabel
al
kidney
spleen
liver
heart
lymph
node
brain
like
excret
blood
urin
describ
earlier
primarili
involv
al
dissolv
influenc
interstiti
fluid
wherea
radioact
detect
lymph
node
spleen
also
involv
al
adjuv
taken
apc
follow
inject
aluminum
hydroxid
adjuv
contain
mg
al
normal
plasma
concentr
ng
alml
rose
approxim
ng
alml
flarend
rabbit
accord
calcul
flarend
similar
al
dose
inject
human
provid
similar
clear
kinet
exist
would
lead
estim
increas
serum
al
ng
alml
equal
normal
level
approxim
ng
alml
appli
dose
mg
al
correspond
normal
use
human
vaccin
seem
amount
aluminum
administ
via
vaccin
contribut
significantli
normal
exposur
aluminum
human
serum
level
aluminum
aluminum
hydroxid
aluminum
phosphat
adjuv
use
half
centuri
gener
regard
safe
use
accord
current
immun
schedul
us
ncvdg
work
group
safeti
evalu
vaccin
adjuv
particip
us
food
drug
administr
repres
conclud
extens
experi
class
adjuv
vaccin
use
indic
safe
issu
extens
review
previous
evid
aluminum
adjuv
immunogen
act
hapten
accordingli
like
caus
harm
immun
complex
reaction
observ
contact
hypersensit
reaction
commonli
seen
aluminum
adjuv
pyrogen
evid
carcinogen
teratogen
attribut
use
case
local
reaction
report
may
includ
swell
indur
erythema
cutan
nodul
persist
week
sometim
longer
report
often
describ
case
hyposensit
allerg
patient
receiv
larg
number
inject
adsorb
allergen
extract
limit
period
vaccin
program
sweden
elisabeth
bergfor
colleagu
found
itch
local
reaction
vaccine
number
side
effect
observ
vaccin
adjuv
vaccin
must
howev
attribut
vaccin
preserv
like
thiomers
betapropriolacton
formaldehyd
mention
bacteri
toxin
antigen
prepar
signific
resourc
spent
throw
light
possibl
link
aluminum
exposur
preval
alzheim
diseas
research
found
aluminum
deposit
ad
brain
tissu
biopsi
wherea
other
later
report
suggest
aluminum
detect
artifact
caus
stain
reagent
use
prepar
specimen
canadian
alzheim
societi
http
wwwalzheimercaenresearch
alzheimersdiseaseresearchaluminum
conclud
webpag
point
convinc
evid
aluminum
increas
person
risk
develop
alzheim
diseas
aluminum
calcium
adjuv
along
waterinoil
emuls
regard
depotform
repositori
adjuv
adjuv
format
temporari
inflammatori
focu
attract
immunocompet
cell
shortli
inject
must
expect
upon
inject
macrophag
attract
site
phagocyt
clear
inoculum
local
reaction
may
neglig
inoculum
rapidli
dispers
inject
site
howev
inoculum
resid
prolong
period
inject
site
case
repositori
adjuv
like
miner
adjuv
waterinoil
emuls
situ
accumul
phagocyt
immunocompet
cell
may
case
manifest
inflammatori
focu
accompani
transient
swell
local
irrit
red
observ
aluminumadsorb
vaccin
give
rise
local
reaction
unadsorb
vaccin
plain
toxoid
could
part
explain
plain
toxoid
vaccin
dispers
inject
site
local
reaction
establish
visibl
palpabl
reaction
inject
site
principl
non
grata
hinder
obtain
hypothet
nonreactogen
ideal
adjuv
howev
import
realiz
mechan
describ
part
normal
function
immun
system
henc
use
repositori
adjuv
without
temporarili
also
induc
inflammatori
focu
around
inoculum
may
achiev
inconsist
observ
regard
whether
adsorpt
onto
aluminum
adjuv
lead
increas
decreas
vaccin
reactogen
howev
butler
et
al
found
adsorpt
onto
aluminum
hydroxid
alhydrogel
significantli
reduc
side
effect
combin
diphteriatetanuspertussi
dtp
vaccin
bind
affin
lipopolysaccharid
lp
aluminum
hydroxid
well
establish
much
higher
aluminum
phosphat
approxim
mgmg
al
versu
approxim
mgmg
al
differ
ascrib
phosphat
group
lp
give
higher
degre
ligand
exchang
aluminum
hydroxid
aluminum
phosphat
conceiv
acut
toxic
reduc
adsorb
vaccin
simpli
delay
releas
toxic
vaccin
constitu
like
pertussi
toxin
peptidoglycan
gramneg
cell
wall
lp
inject
site
norimatsu
found
adsorpt
lp
onto
aluminum
hydroxid
prior
inject
inhibit
mitig
system
effect
like
trembl
transient
leucopenia
elev
serum
tnfa
otherwis
observ
follow
im
inject
lp
salin
also
level
administr
lp
reduc
lp
adsorb
aluminum
hydroxid
prior
inject
attempt
made
link
presenc
local
inflammatori
focu
myofascii
macrophag
myofasci
mmf
im
inject
aladjuv
vaccin
condit
like
myalgia
muscl
fatigu
manifest
partli
explain
format
adjuv
granuloma
muscl
tissu
howev
mmf
also
claim
associ
neurolog
disord
obviou
etiolog
relat
vaccin
howev
correl
associ
statist
challeng
due
high
vaccin
coverag
western
countri
expect
statist
patient
suffer
wide
rang
unrel
diseas
would
vaccin
alcontain
vaccin
point
medic
histori
control
studi
cynomolgu
monkey
possibl
detect
histolog
chang
besid
local
inflammatori
focu
abnorm
clinic
sign
associ
vaccin
may
given
subcutan
sc
im
inject
modu
without
import
relat
local
reactogen
immun
sc
rout
vaccin
inoculum
introduc
compart
numer
sensori
neuron
contrast
im
compart
introduct
local
inflammatori
respons
may
easili
lead
irrit
itch
reaction
besid
transient
swell
consequ
inflammatori
focu
form
may
easili
palpabl
skin
immun
im
rout
even
similar
size
swell
may
less
easili
visibl
palpabl
locat
deeper
lie
tissu
evalu
profil
adjuv
possibl
new
applic
adjuv
match
aluminum
adjuv
term
record
efficaci
safeti
profil
period
use
reach
practic
entir
life
span
human
aluminum
adjuv
limit
due
sensit
freez
appar
profil
howev
born
mind
pioneer
work
led
conclus
aluminum
adjuv
gave
fairli
clear
stimul
carri
time
subset
recogn
sinc
anoth
three
effector
tcell
subset
identifi
regulatori
cell
follicular
thelper
cell
fh
addit
research
requir
see
extent
aluminumor
calciumbas
adjuv
may
encompass
also
stimul
tcell
subset
past
year
increas
interest
calcium
phosphat
adjuv
convent
vaccin
also
prepar
adsorb
allergen
calcium
phosphat
natur
constitu
bodi
henc
fulli
physiolog
compat
constitut
interest
altern
aluminum
adjuv
yet
fulli
explor
